The University of Oxford has launched what it says is the world's first phase I clinical trial of a vaccine specifically ...
Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, ...
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
12hon MSN
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion
AstraZeneca entered into an exclusive global license agreement with China’s Dizal Pharmaceutical for the lung cancer ...
SHANGHAI, July 14 (Reuters) - AstraZeneca will pay Dizal Pharmaceutical $600 million upfront for global rights to one of its ...
AstraZeneca Plc will pay China’s Dizal Jiangsu Pharmaceutical Co. $600 million upfront for global rights to a lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results